[1]
|
Involvement of progranulin (PGRN) in the pathogenesis and prognosis of breast cancer
Cytokine,
2022
DOI:10.1016/j.cyto.2022.155803
|
|
|
[2]
|
Involvement of progranulin (PGRN) in the pathogenesis and prognosis of breast cancer
Cytokine,
2022
DOI:10.1016/j.cyto.2022.155803
|
|
|
[3]
|
Tumor Microenvironment
Advances in Experimental Medicine and Biology,
2021
DOI:10.1007/978-3-030-73119-9_22
|
|
|
[4]
|
Tumor Microenvironment
Advances in Experimental Medicine and Biology,
2021
DOI:10.1007/978-3-030-73119-9_22
|
|
|
[5]
|
miRNA Expression Profiles in Luminal A Breast Cancer—Implications in Biology, Prognosis, and Prediction of Response to Hormonal Treatment
International Journal of Molecular Sciences,
2020
DOI:10.3390/ijms21207691
|
|
|
[6]
|
Differential microRNA expression profiles determined by next‑generation sequencing in three fulvestrant‑resistant human breast cancer cell lines
Oncology Letters,
2019
DOI:10.3892/ol.2019.10061
|
|
|
[7]
|
Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index
Diagnostic Pathology,
2016
DOI:10.1186/s13000-016-0520-4
|
|
|
[8]
|
MicroRNA-588 suppresses tumor cell migration and invasion by targeting GRN in lung squamous cell carcinoma
Molecular Medicine Reports,
2016
DOI:10.3892/mmr.2016.5643
|
|
|
[9]
|
Identification of targets of miRNA-221 and miRNA-222 in fulvestrant-resistant breast cancer
Oncology Letters,
2016
DOI:10.3892/ol.2016.5180
|
|
|
[10]
|
Role of ER-α36 in breast cancer by typical xenoestrogens
Tumor Biology,
2015
DOI:10.1007/s13277-015-4006-x
|
|
|
[11]
|
Signaling Pathway of GP88 (Progranulin) in Breast Cancer Cells: Upregulation and Phosphorylation of c-myc by GP88/Progranulin in Her2-Overexpressing Breast Cancer Cells
Breast Cancer: Basic and Clinical Research,
2015
DOI:10.4137/BCBCR.S29371
|
|
|